News
17h
TipRanks on MSNAbbVie and Genmab’s Promising Study on Epcoritamab for Non-Hodgkin LymphomaThe study involves testing epcoritamab, administered subcutaneously, in combination with oral and intravenous anti-neoplastic agents. These include drugs like lenalidomide, ibrutinib, and polatuzumab ...
Stephen Lea, 33, from Bootle in Merseyside, was fit and healthy when he started experiencing back pain last year.
41m
News-Medical.Net on MSNInsecticide exposure could impair mental function in older adultsThe study investigates the link between pesticide exposure and cognitive impairment in older adults, suggesting a need for ...
BeOne Medicines - the Sino-American oncology specialist formerly known as BeiGene (SHA: 688235) - has announced that the ...
What started as a coping mechanism during cancer recovery then turned into a full-time career, with the couple now sharing ...
19h
GlobalData on MSNCTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031The US dominates overall market sales, yet GlobalData research indicates that China is shaping up to be a formidable presence ...
Paul Harvey’s iconic sign-off, “And now you know the rest of the story,” captivated more than 24 million weekly listeners ...
A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.
5h
News-Medical.Net on MSNNew chemotherapy regimen improves fertility outcomes in young Hodgkin's lymphoma patientsYoung patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...
18h
Cornwall Live on MSNMan, 33, given months to live after devastating diagnosis following back painAged just 33, Stephen was told the news after he went for an MRI scan following back pain. 'One doctor predicted weeks to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results